AstraZeneca vaccine: WHO tells Europe benefits outweigh risks as countries halt use

The benefits of AstraZeneca’s COVID-19 vaccine far outweigh any risks and countries across Europe should continue to use it to help save lives, the World Health Organisation’s European director says.

Hans Kluge noted that Europe’s medicines regulators are investigating a small number of cases of blood clots in the region that have prompted around a dozen EU governments to suspend us of the AstraZeneca shot.

“As of now, we do not know whether some or all of the conditions have been caused by the vaccine or by other coincidental factors,” he said.

“At this point in time, however, the benefits of the AstraZeneca vaccine far outweigh its risks – and its use should continue, to save lives.”

The European Medicines Agency (EMA) has said so far said it has found no causal link between the vaccine and any clotting or blood coagulation reports.

WHO has told European nations the benefits of AstraZeneca’s COVID-19 vaccine far outweigh any risks. Credit: REUTERS

What's your reaction?

In Love
Not Sure

You may also like

More in:Lifestyle

Leave a reply

Your email address will not be published. Required fields are marked *